Commit To Purchase Fulcrum Therapeutics At $7, Earn 67.7% Annualized Using Options
July 24, 2024 at 11:35 AM EDT
Investors eyeing a purchase of Fulcrum Therapeutics Inc (FULC) stock, but tentative about paying the going market price of $8.92/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2025 put at the $7 strike, which has a bid at the time of this writing of $2.30..